3’-O-MOE-A (Bz) -2’-CED-phosphoramidite
3’-O-MOE-A (Bz) -2’-CED-phosphoramidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
[256224-01-8]
UNSPSC
12352005
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/3-o-moe-a-bz-2-ced-phosphoramidite.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC=CC=C1)NC2=NC=NC3=C2N=CN3[C@H]4[C@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@H](OCCOC)[C@@H](COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O4
Molecular Formula
C50H58N7O9P
Molecular Weight
932.01
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PRAS40, phosphorylated (Thr246) (Proline-rich AKT1 substrate 1, 40kD proline-rich AKT substrate, AKT1S1) (MaxLight 550) discontinued
Glutamine Synthetase (GS, Glutamate Decarboxylase, Glutamate-ammonia Ligase, GLUL, GLNS) (FITC)
